1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Technology
3.2. Snippet by Product and Services
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing number of chronic disease testing
4.1.2. Restraints
4.1.2.1. High costs and services
4.1.3. Opportunity
4.1.3.1. Technological advancements
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Analysis
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Fluorescence-activated cell sorting (FACS)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Magnetic-activated cell sorting (MACS)
9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
9.5. Density Gradient Centrifugation
9.6. Immunodensity Cell Separation
9.7. Sedimentation
9.8. Others
10. By Product and Services
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
10.1.2. Market Attractiveness Index, By Product and Services
10.2. Cell Sorters*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cell Sorting Reagents & Consumables
10.4. Cell Sorting Services
11. By Application
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Clinical Applications*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Applications
11.3.1. Immunology & Cancer Research
11.3.2. Stem Cell Research
11.3.3. Drug Discovery
11.3.4. Other Research Applications
12. By End user
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
12.1.2. Market Attractiveness Index, By End user
12.2. Research Institutes*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Pharmaceutical & Biotechnology Companies
12.4. Hospitals and Clinical Testing Laboratories
12.5. Medical Schools and Academic Institutions
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. The U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. The U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies
15. Company Profiles
15.1. Bio-Rad Laboratories, Inc.*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Sony Biotechnology Inc.
15.3. BD
15.4. Merck KGaA
15.5. Danaher Corporation
15.6. Miltenyi Biotec GmbH
15.7. Affymetrix, Inc
15.8. Sysmex Partec GmbH
15.9. On-Chip Biotechnologies Co., Ltd.
15.10. Thermo Fisher Scientific
16. Appendix
16.1. About Us and Services
16.2. Contact Us